Monoamine oxidase inhibitors in rheumatoid arthritis - anti-tumor necrosis factor?

被引：6

作者：

Altschuler, EL ^{[1
]}

机构：

[1] Univ Calif San Diego, Inst Neural Computat, Brain & Percept Lab, La Jolla, CA 92093 USA

来源：

INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY | 2000年 / 22卷 / 11期

关键词：

D O I：

10.1016/S0192-0561(00)00047-3

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：1007 / 1008

页数：2

共 10 条

[1] Catecholamines increase monocyte TNF receptors and inhibit TNF through β2-adrenoreceptor activation [J].

Guirao, X ;

Kumar, A ;

Katz, J ;

Smith, M ;

Lin, E ;

Keogh, C ;

Calvano, SE ;

Lowry, SF .

AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 1997, 273 (06) :E1203-E1208

[2] Crohn's disease remission with phenelzine treatment [J].

Kast, RE .

GASTROENTEROLOGY, 1998, 115 (04) :1034-1035

[3] REMISSION OF RHEUMATOID-ARTHRITIS AND OTHER DISORDERS OF IMMUNITY IN PATIENTS TAKING MONOAMINE-OXIDASE INHIBITORS [J].

LIEB, J .

INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1983, 5 (04) :353-357

[4] Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate:: a randomised phase III trial [J].

Maini, R ;

St Clair, EW ;

Breedveld, F ;

Furst, D ;

Kalden, J ;

Weisman, M ;

Smolen, J ;

Emery, P ;

Harriman, G ;

Feldmann, M ;

Lipsky, P .

LANCET, 1999, 354 (9194) :1932-1939

[5] Release of tumor necrosis factor-α from coronary smooth muscle:: Activation of NF-κB and inhibition by elevated cyclic AMP [J].

Newman, WH ;

Zhang, LM ;

Lee, DH ;

Dalton, ML ;

Warejcka, DJ ;

Castresana, MR ;

Leeper-Woodford, SK .

JOURNAL OF SURGICAL RESEARCH, 1998, 80 (02) :129-135

[6] Amelioration of collagen II-induced arthritis in rats by the type IV phosphodiesterase inhibitor Rolipram [J].

Nyman, U ;

Mussener, A ;

Larsson, E ;

Lorentzen, J ;

Klareskog, L .

CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1997, 108 (03) :415-419

[7] CHARACTERIZATION OF CAMP-DEPENDENT INHIBITION OF LPS-INDUCED TNF-ALPHA PRODUCTION BY ROLIPRAM, A SPECIFIC PHOSPHODIESTERASE-IV (PDE-IV) INHIBITOR [J].

PRABHAKAR, U ;

LIPSHUTZ, D ;

BARTUS, JO ;

SLIVJAK, MJ ;

SMITH, EF ;

LEE, JC ;

ESSER, KM .

INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1994, 16 (10) :805-816

[8] THE ANTIDEPRESSANT ROLIPRAM SUPPRESSES CYTOKINE PRODUCTION AND PREVENTS AUTOIMMUNE ENCEPHALOMYELITIS [J].

SOMMER, N ;

LOSCHMANN, PA ;

NORTHOFF, GH ;

WELLER, M ;

STEINBRECHER, A ;

STEINBACH, JP ;

LICHTENFELS, R ;

MEYERMANN, R ;

RIETHMULLER, A ;

FONTANA, A ;

DICHGANS, J ;

MARTIN, R .

NATURE MEDICINE, 1995, 1 (03) :244-248

[9] Randomised controlled trial of CDP571 antibody to tumour necrosis factor-alpha in Crohn's disease [J].

Stack, WA ;

Mann, SD ;

Roy, AJ ;

Heath, P ;

Sopwith, M ;

Freeman, J ;

Holmes, G ;

Long, R ;

Forbes, A ;

Kamm, MA ;

Hawkey, CJ .

LANCET, 1997, 349 (9051) :521-524

[10] MOLECULAR PHARMACOLOGY OF THE BETA-ADRENERGIC-RECEPTOR ON THP-1 CELLS [J].

TALMADGE, J ;

SCOTT, R ;

CASTELLI, P ;

NEWMANTARR, T ;

LEE, J .

INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1993, 15 (02) :219-228

← 1 →